SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 2174149

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 2174149

Global Precision Medicine Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 201 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The global precision medicine market size is expected to reach USD 215.16 Billion in 2034 from USD 89.99 Billion in 2025, growing at a CAGR of 10.17% during 2026-2034.The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Other Technology

By Application

  • Oncology
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Immunology
  • Genetic Diseases
  • Other Applications

By End-Use

  • Pharmaceutical Companies
  • Diagnostic Companies
  • Healthcare and IT Firms
  • Others

COMPANIES PROFILED

  • Roche
  • Thermo Fisher Scientific
  • Illumina
  • QIAGEN
  • Abbott
  • Foundation Medicine
  • Guardant Health
  • Natera
  • Exact Sciences
  • Tempus AI
  • NeoGenomics
  • Caris Life Sciences
  • Myriad Genetics
  • Veracyte
  • Novartis
  • AstraZeneca
  • Pfizer
  • Bristol Myers Squibb
  • Merck & Co.
  • Johnson & Johnson
Product Code: VMR11214898

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECISION MEDICINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Big Data Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Gene Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Companion Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Other Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECISION MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Central Nervous System Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Genetic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECISION MEDICINE MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostic Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Healthcare and IT Firms Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECISION MEDICINE MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Technology
    • 7.2.2 By Application
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Technology
    • 7.3.2 By Application
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Spain
    • 7.3.9 Russia
    • 7.3.10 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Technology
    • 7.4.2 By Application
    • 7.4.3 By End-use
    • 7.4.4 China
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 India
    • 7.4.8 Australia
    • 7.4.9 South East Asia
    • 7.4.10 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Technology
    • 7.5.2 By Application
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Technology
    • 7.6.2 By Application
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PRECISION MEDICINE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Roche
    • 9.2.2 Thermo Fisher Scientific
    • 9.2.3 Illumina
    • 9.2.4 QIAGEN
    • 9.2.5 Abbott
    • 9.2.6 Foundation Medicine
    • 9.2.7 Guardant Health
    • 9.2.8 Natera
    • 9.2.9 Exact Sciences
    • 9.2.10 Tempus AI
    • 9.2.11 NeoGenomics
    • 9.2.12 Caris Life Sciences
    • 9.2.13 Myriad Genetics
    • 9.2.14 Veracyte
    • 9.2.15 Novartis
    • 9.2.16 AstraZeneca
    • 9.2.17 Pfizer
    • 9.2.18 Bristol Myers Squibb
    • 9.2.19 Merck & Co
    • 9.2.20 Johnson & Johnson
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!